India is still considered as one of the prominent suppliers of medicines, APIs, formulations, intermediates and other raw material for pharmaceutical industry. The right selection of supplier not only depends on a good quote but it also requires to get good specification, quality, licence, good logistics and documents meeting the target market requirements.
In just about three years from now, 2026, the selection process will be even more difficult in terms of quality and regulatory compliance. As per the Ministry of Commerce and Industry, the pharmaceutical exports from India stood at about US$ 30.47 billion in FY 2024-25 while the domestic market is about US$ 60 billion. This is indicative of the magnitude of the industry but not all the suppliers can match up to all the buyers' requirement.
"Pharmaceutical products suppliers" include different types of businesses. Some manufacture finished medicines. Others may supply APIs, intermediates, or excipients. The distributors/exporters buy these products from the manufacturers that are registered with the authority and distribute the same in the market. Before meeting the suppliers, you will have to discuss the type of product, its grade, use, and destination market for the products.
India has a diverse pharmaceutical ecosystem including formulators, API manufacturers, CDMOs, wholesalers, exporters, and specialized distributors. This variety may assist buyers to compare various supply scenarios, including factory direct procurement and purchasing from a distributor. The optimal scenario will vary depending on the volume, technical nature of the order, documentation needed and the buyer’s qualification of the manufacturing facility.
Products of Indian pharmaceutical firms are exported to markets around the world. Data published by government sources indicates that exports from India include both highly regulated and emerging markets. Yet the acceptability of the regulatory environment is product- and market-dependent. It would be necessary to verify the track record of exports in accordance with the specific product, manufacturing facility, and destination country.
As far as mass purchasing or repeat purchasing of APIs, intermediates, or formulations goes, then an Indian vendor will be able to provide a smooth sailing for the manufacturing plans and help to draw up the deal and purchase again. Do not think only about how cheap each piece is, but think about what it will cost to deliver it to you.
In addition to manufacturers, buyers may require contract manufacturers, testing services, packaging firms and exporters who understand how to handle paperwork and logistics. It will be useful to formulate a procurement brief in order to find the right kind of partner rather than ask the same question to different suppliers.
Authenticate the official name of the firm, its address, legal credentials, and its role within the business process. If the firm claims that it is a factory, then proof in support of this claim has to be shown. The credentials and the GMP certification can be authenticated by the relevant authority and should not be considered just because of the logo, certificate image, or the market place website of the supplier.
Requirements of license as well as quality certification that pertain to manufacture or wholesale. It is essential for the buyer to verify the scope of the certificate, address of the manufacturing unit, category of the item, validity period, and issuing authority. The revised Schedule M of the Drugs Rules lays down the GMP requirements for the premises, plant, and equipment of Indian manufacturers. Practices (GMP) requirements for premises, plant, and equipment of Indian manufacturers. By 2026, buyers will have to demand the current status of compliance of the supplier rather than assume its compliance since the supplier is in India.
The GMP certificate does not imply approval for all types of products and destinations. API products, sterile products, finished dosage forms, and export licenses are different.
In the case of API and raw material, always try to consult any available and updated documentation such as CoA, SDS, technical data sheet, and retest data sheet, etc. According to the type of material, there is a need for documentation regarding the impurity, residual solvents, elemental impurity, allergen, source of animals, etc.
How does the supplier deal with deviations, out of specification results, complaints, change control, recall, CAPA, etc? In case of important materials or high volume contract, there might be a need to conduct a quality questionnaire, a remote audit or an onsite audit. This is proportional to product risk and organization quality systems.
The quotation should include the following: product grades or specifications, quantities, price and currency, MOQ, packing, lead time, terms of payment, Incoterm, shelf-life or period of retesting, and shipment from quotation origin. Further, the following should also be available in relation to the payments: independent testing, shipping, insurance, and any discrepancies before placing the purchase order.
Speed and accuracy are important right from the beginning. Check the speed and ability of the supplier in dealing with technical matters, documentation and communication in case of any delays. If this is an ongoing supply relationship, check their capacity in forecasting, safety stocks, limits of capacity and contingency planning. A very low quotation has no value if they cannot deliver within the required time frame.
|
Evaluation area |
What to check |
Why it matters |
|
Company identity |
Legal name, address, manufacturer/distributor status |
Reduces counterparty and misrepresentation risk |
|
Regulatory status |
Applicable licences, GMP evidence, site and product scope |
Confirms fit for the product and target market |
|
Product quality |
Specification, CoA, traceability and change control |
Supports consistent quality and technical assessment |
|
Supply capability |
Available capacity, lead time, MOQ and continuity plan |
Helps prevent stock-outs and production delays |
|
Commercial terms |
Landed cost, payment terms, packaging and Incoterms |
Enables a like-for-like comparison of offers |
|
Communication |
Response quality, document accuracy and escalation process |
Shows whether issues can be resolved efficiently |
B2B portals dedicated to the pharmaceutical and chemicals industry may help in identifying potential manufacturers, distributors, and traders along with evaluating their proposals and distributing RfQs. This will particularly benefit situations wherein the buyer is looking out for other suppliers for APIs, intermediates, excipients, or other raw materials. The list on a marketplace is meant to be just a starting point – not a replacement for supplier qualification, regulatory compliance or any other independent verification.
The ChemDmart platform can facilitate B2B supplier discovery and sourcing processes for pharmaceutical and chemical businesses. The purchasers will be able to employ a detailed sourcing brief which contains details of the commodity needed, its grade, quantity, intended market, and documentation and delivery.
Search for pharmaceutical products suppliers in India in 2026 must be based on a well-organised set of criteria that includes consideration of product quality and its regulatory aspects, as well as reliability and commercial value of the offer. It is important to start with setting your own requirements, verify the supplier's identification and qualifications, check out its technical documentation and compare offers according to total cost criterion.For the selection of suppliers for critical parts and long-term contracts, make the supplier qualification a part of the procurement process at an early stage.